← All trials
NCT03188627
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 19, 2017
- Primary completion
- Feb 18, 2019
- Completion date
- Aug 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Regend TherapeuticsLead sponsor
- People's Liberation Army of ChinaCollaborator
- Regend TherapeuticsReponsible party - principal investigator
- Huazhong University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.